BeStock  
Stocks › Biotechnology › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2154Biotechnology
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership106.8%-5.49 pts vs. prior quarter
Institutions holding288+2 vs. prior quarter
Insider trades (recent)35 buys / 15 sellsNet buying
Short interest11.69% of floatDays to cover 9.6 · as of 30 Oct 2026
Short-sale volume share17.2%5-day average of daily volume

Short-sale volume as % of daily volume

6%13%20%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$12.57M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$7.6MSuper−$5.0MBig−$12.0MMid−$2.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.4% of shares outstanding.

Largest holders

  • OrbiMed Advisors LLC14.17%
  • Paradigm Biocapital Advisors LP9.33%
  • RA Capital Management, L.P.7.67%
  • BlackRock6.64%
  • Janus Henderson Group plc5.55%
  • FMR5.05%
  • Novo Holdings A/S4.89%
  • Driehaus Capital Management LLC4.32%

By investor type

  • Mutual Fund42.10%
  • VC/PE Fund35.28%
  • Hedge Fund23.75%
  • Public Company3.91%
  • Government Pension Fund0.60%
  • Sovereign Wealth Fund0.47%
  • Private Company0.45%
  • Individual/Insider0.20%

Reported short interest has risen from 8.91% to 11.69% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +735,202 0.7%
BlackRock Mutual Fund 2026/Q3 +667,890 6.6%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +655,306 0.6%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +166,751 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +108,252 2.1%
FMR Mutual Fund 2026/Q3 +4,472,077 5.1%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +2,850,417 9.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +747,091 0.7%
Tyro Capital Management, LLC Hedge Fund 2026/Q3 +612,965 0.6%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +462,000 0.4%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +426,597 1.1%
Integral Health Asset Management, LLC Hedge Fund 2026/Q3 +400,000 1.8%
AllianceBernstein Mutual Fund 2026/Q3 +396,855 2.0%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +384,232 2.0%
Raymond James Financial, Inc. Public Company 2026/Q3 +297,887 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Michael Nofi Chief Financial Officer Derivative Exercise and Sale -4,442 $45.43 6,495
9 Nov 2026 Michael Nofi Chief Financial Officer Derivative Exercise and Retained +6,495 – 6,495
30 Sep 2026 Jonathan Fox Independent Director Other Acquisition +308 – 25,141
12 Aug 2026 Joanne Donovan Chief Medical Officer Derivative Exercise and Sale -9,441 $44.52 8,625
11 Aug 2026 Kevin Koch Chief Executive Officer Derivative Exercise and Sale -17,971 $44.33 52,488
11 Aug 2026 Kevin Koch Chief Executive Officer Other Derivative Acquisition +100,000 – 100,000
11 Aug 2026 Kevin Koch Chief Executive Officer Other Derivative Acquisition +200,000 $43.56 200,000
11 Aug 2026 Kevin Koch Chief Executive Officer Derivative Exercise and Retained +21,873 – 52,488
11 Aug 2026 John Moore General Counsel Derivative Exercise and Sale -5,016 $44.50 17,697
11 Aug 2026 John Moore General Counsel Other Derivative Acquisition +32,500 – 32,500
11 Aug 2026 John Moore General Counsel Other Derivative Acquisition +65,000 $43.56 65,000
11 Aug 2026 John Moore General Counsel Derivative Exercise and Retained +7,483 – 17,697
11 Aug 2026 Joanne Donovan Chief Medical Officer Other Derivative Acquisition +32,500 – 32,500
11 Aug 2026 Joanne Donovan Chief Medical Officer Other Derivative Acquisition +65,000 $43.56 65,000
11 Aug 2026 Joanne Donovan Chief Medical Officer Derivative Exercise and Retained +3,371 – 8,625
11 Aug 2026 Behrad Derakhshan Chief Operating Officer Derivative Exercise and Sale -5,100 $44.50 31,826
11 Aug 2026 Behrad Derakhshan Chief Operating Officer Other Derivative Acquisition +50,000 – 50,000
11 Aug 2026 Behrad Derakhshan Chief Operating Officer Other Derivative Acquisition +100,000 $43.56 100,000
11 Aug 2026 Behrad Derakhshan Chief Operating Officer Derivative Exercise and Retained +8,181 – 31,826
11 Aug 2026 Michael Nofi Chief Financial Officer Other Derivative Acquisition +24,375 – 24,375

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 12,696,203 11.7% 9.6
15 Oct 2026 11,751,785 10.8% 8.5
30 Sep 2026 11,224,347 10.3% 5.6
15 Sep 2026 9,543,843 8.8% 8.0
31 Aug 2026 9,346,141 8.6% 8.0
14 Aug 2026 9,675,389 8.9% 6.4

Discussion

No comments yet — be the first to weigh in on EWTX.

Sign in to join the discussion.

Scroll to Top